The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHermes Pac. Regulatory News (HPAC)

Share Price Information for Hermes Pac. (HPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 40.00
Ask: 55.00
Change: 0.00 (0.00%)
Spread: 15.00 (37.50%)
Open: 47.50
High: 47.50
Low: 47.50
Prev. Close: 47.50
HPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

20 Dec 2022 07:00

RNS Number : 2213K
Hermes Pacific Investments PLC
20 December 2022
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

20 December 2022

 

HERMES PACIFIC INVESTMENTS PLC

(AIM: HPAC)

 

Unaudited interim results for the six months ended 30 September 2022

 

 

Chairman's Statement

I am pleased to report the results for Hermes Pacific Investments plc ("HPAC" or the "Company") for the six months ended 30 September 2022 (the "Period"). During the Period the Company made a loss on ordinary activities before taxation of £44,000 which is marginally less than the loss reported for the corresponding period in the previous year. The Company's financial performance is in line with our expectations. HPAC has generated small amount of revenue in the Period through the rental income on our residential property. We continue to manage our costs effectively whilst keeping its spending to a minimum. There was no material change in the value of the Company's existing investments from that as at 31 March 2022. The Company is also considering possible investment opportunities which would be compatible with its investment strategy. As at 30 September 2022 the Company had net assets of £3,460,000 of which cash was £2,625,000.

Review of the Company's activities

Hermes Pacific Investments plc is an investing company and its focus is to invest principally, but not exclusively, in the property sector.

In the Period the Company purchased a two-bedroom leasehold flat and a single garage in Westcliff-on-sea, Southend-on-Sea as announced on 19 May 2022. The purchase price of £594,907 was funded from the Company's existing cash resources. This flat has been now been rented out on assured shorthold tenancy agreement.

 

Inflation levels are compared to historic levels quite high at the moment and in response the Bank of England has been increasing the base rate of interest during 2022 which is currently standing at 3.5% and this has also impacted the mortgage rates which have increased substantially compared to the recent past. The housing market is likely to slow down and some predict that property prices will fall in the near term. We will therefore proceed very carefully before we make further investments in the property sector.

 

I would like to thank shareholders for their continued support.

 

 

Haresh Kanabar

Chairman

 

 

 

Contacts:

Hermes Pacific Investments plc

www.hermespacificinvestments.com

Haresh Kanabar, Chairman

+44 (0) 7802858893

WH Ireland Limited

https://www.whirelandplc.com/capital-markets

Mike Coe, Sarah Mather

+44 (0)20 7220 1666

Unaudited Income Statement for the six months ended 30 September 2022

 

Note

 

Unaudited

6 Months

ended

30 September 2022

 £'000

Unaudited

6 Months

ended

30 September 2021

£'000

 

 

 

Audited

Year ended

31 March 2022

£'000

Continuing activities

Revenue

7

-

-

Cost of sales

-

-

-

 

 

 

Gross loss/profit

7

-

 

-

Other operating income

-

-

-

 

Administrative expenses

(53)

(50)

(111)

 

 

 

Operating loss

(46)

(50)

(111)

Finance income

2

-

6

Finance costs

-

-

-

 

 

 

Loss on ordinary activities before taxation

(44)

(50)

(105)

 

Tax expense

-

-

 

-

 

 

 

Loss for the period from continuing activities

 

(44)

(50)

(105)

 

Other comprehensive income

 

Gain arising in the year

10

11

37

 

 

 

 

Gain/(Loss) for the period

(34)

(39)

(68)

 

 

 

 

Basic and diluted loss per share

From continuing operations

3

(1.9)p

(2.2)p

(4.5)p

 

 

 

Unaudited Balance Sheet as at 30 September 2022

 

Note

 

Unaudited

6 Months

ended

30 September 2022

 £'000

 

 

 

Unaudited

6 Months

ended

30 September 2021

£'000

 

Audited

Year ended

31 March 2022

£'000

Assets

Investments and fixed assets

Investments and property

856

180

211

 

 

 

 

856

180

211

Current assets

Trade and other receivables

4

4

10

Cash and cash equivalents

2,625

3,358

3,284

 

 

 

Total current assets

2,629

3,362

 

3,294

 

 

 

 

Total assets

3,485

3,542

3,505

 

Liabilities

Current liabilities

Trade and other payables

(25)

(27)

(19)

 

 

 

Net assets

3,460

3,515

3,486

 

 

 

 

Equity

Share capital

2,333

2,333

2,333

Deferred share capital

1,243

1,243

1,243

Share premium account

5,781

5,781

5,781

Share based payments reserves

Revaluation reserve

139

56

139

12

139

38

Retained losses

(6,092)

 

(5,993)

 

(6,048)

 

 

 

Equity attributable to equity holders of the parent

3,460

3,515

3,486

 

 

 

 

 

 

Unaudited Statement of Changes in Equity

 

 

 

Ordinary share capital

 

Deferred share capital

 

 

Share premium

Share

based

payments

reserves

 

 

Revaluation reserve

 

 

Retained earnings

 

 

 

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

Six months ended 30 September 2021

At 31 March 2021

2,333

1,243

5,781

139

1

(5,943)

3,554

Total comprehensive gain/(loss) for the period

 

-

 

-

 

-

 

-

 

11

 

(50)

 

(39)

At 30 September 2021

2,333

1,243

5,781

139

12

(5,993)

3,515

 

 

 

Period ended 31 March 2022

At 30 September 2021

2,333

1,243

5,781

139

12

(5,993)

3,515

Total comprehensive gain/(loss) for the period

 

-

 

-

 

-

 

-

 

26

 

(55)

 

(29)

At 31 March 2022

2,333

1,243

5,781

139

38

(6,048)

3,486

 

Six months ended 30 September 2022

At 31 March 2022

2,333

1,243

5,781

139

38

(6,048)

3,486

Total comprehensive gain/(loss) for the period

 

-

 

-

 

-

 

-

 

18

 

(44)

 

(26)

At 30 September 2022

2,333

1,243

5,781

139

56

(6,092)

3,460

 

Unaudited Cash Flow Statement for the six months ended 30 September 2022

 

Note

 

Unaudited

6 Months

ended

30 September 2022

 £'000

 

 

Unaudited

6 Months

ended

30 September 2021

£'000

Audited

Year ended

31 March 2022

£'000

Cash outflow from operating activities

 

(40)

(42)

(117)

 

 

 

 

 

 

Net cash flow from operating activities

 

(40)

(42)

(117)

 

 

 

 

 

 

Cash flows from financing activities

 

Other income

 

16

5

6

Purchase of property

 

(635)

-

-

 

 

 

 

Net cash from financing activities

 

(619)

5

6

 

 

Decrease in cash and cash equivalents

 

(659)

(37)

 

(111)

Cash and cash equivalents at start of the period

 

3,284

3,395

3,395

 

 

 

 

 

Cash and cash equivalents at end of the period

 

2,625

3,358

3,284

 

 

 

 

 

 

Notes to the unaudited consolidated interim statement for the period ended 30 September 2022

 

1. Basis of preparation

 

Hermes Pacific Investments plc. is a public limited company incorporated and domiciled in the United Kingdom. The Company is an AIM listed investment vehicle. These Interim accounts have been prepared using the accounting policies to be applied in the annual report and accounts for the period ending 31 March 2023. These are consistent with those included in the previously published annual report and accounts for the period ended 31 March 2022, which have been prepared in accordance with IFRS as adopted by the European Union. The preparation of the interim statement requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. Actual results may differ from these estimates.

 

The interim financial statements are unaudited and do not constitute statutory accounts as defined in section 434(3) of the Companies Act 2006. 

 

The figures for the year ended 31 March 2022 have been extracted from the audited annual report and accounts that have been delivered to the Registar of Companies. BSG Valentine, the Company's auditors, reported on those accounts. Their report was unqualified and did not contain a statement under section 498 of that Companies Act 2006.

 

2. Accounting policies

 

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

 

Going concern

 

The financial statements have been prepared on a going concern basis as, after making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future at the time of approving the financial statements.

 

Critical accounting estimates and judgments

 

The preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of the company's accounting policies with respect to the carrying amounts of assets and liabilities at the date of the financial statements, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. The judgements, estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, including current and expected economic conditions. Although these judgements, estimates and associated assumptions are based on management's best knowledge of current events and circumstances, the actual results may differ. Estimates and underlying assumptions are reviewed on an on-going basis. Revisions to accounting estimates are recognised in the year in which the estimate is revised and in any future years affected.

 

The judgements, estimates and assumptions which are of most significance to the Company are detailed below:

 

Valuation of share based payments

 

The charge for share based payments is calculated in accordance with the accounting policy as set out below. The model requires highly subjective assumptions to be made including the future volatility of the Company's share price, expected dividend yield and risk-free interest rates.

 

Revenue recognition

Revenue represents the fair value of the consideration received or receivable, net of Value Added Tax, for goods sold and services provided to customers after deducting discounts. Revenue is recognised when the significant risks and rewards of ownership are transferred.

 

Deferred taxation

Deferred taxation is provided in full using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred tax is determined using tax rates that have been enacted or substantially enacted by the balance sheet date and are expected to apply when the related deferred tax asset is realised or the deferred tax liability is settled.

 

Deferred tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.

 

Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short term highly liquid funds with original maturities of three months or less and bank overdrafts. Bank overdrafts are shown within borrowing in current liabilities on the balance sheet.

 

Investments available for sale

Investments classified as available for sale are initially recorded at fair value including transaction costs. Quoted investments are held at fair value and measured either at bid price or latest traded price, depending on convention of the exchange on which the investment is quoted. Such instruments are subsequently measured at fair value with gains and losses being recognised directly in equity until the instrument is disposed of or is determined to be impaired, at which time the cumulative gain or loss previously recognised in equity is recycled to the income statement and recognised in profit or loss for the period. Impairment losses are recognised in the Income Statement when there is objective evidence of impairment. 

 

Financial instruments

Financial assets and liabilities are recognised in the balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Trade and other receivables

Trade receivables are measured at cost less any provision necessary when there is objective evidence that the Company will not be able to collect all amounts due.

 

Trade and other payables

Trade and other payables are not interest bearing and are measured at original invoice amount.

 

3. Loss per ordinary share

 

Unaudited

6 Months

ended

30 September 2022

 £'000

Unaudited

6 Months

ended

30 September 2021

£'000

 

 

 

Audited

Year ended

31 March 2022

£'000

Basic

Loss from continuing activities

(44)

(50)

(105)

 

 

 

Total loss

 

(44)

(50)

(105)

Basic loss per share (pence)

From continuing operations

(1.9)p

(2.2)p

(4.5)p

 

 

 

(1.9)p

(2.2)p

(4.5)p

 

 

 

 

Weighted average number of shares

2,333,295

2,333,295

2,333,295

 

 

 

 

There was no dilutive effect from the share options outstanding during the period.

 

 

4. Copies of this statement will be available on the Company's website www.hermespacificinvestments.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FFFFMUEESEDE
Date   Source Headline
15th Dec 20237:00 amRNSInterim Results
26th Sep 202312:00 pmRNSFinal Results
20th Dec 20227:00 amRNSInterim Results
26th Sep 20227:00 amRNSFinal Results
19th May 20227:00 amRNSProperty purchase
14th Dec 202112:37 pmRNSResult of General Meeting
13th Dec 20217:00 amRNSInterim Results
22nd Nov 20217:00 amRNSProposed Change of Investing Policy
22nd Sep 20217:00 amRNSFinal Results
3rd Feb 20213:11 pmRNSDirectorate Change
18th Dec 20207:00 amRNSInterim results
28th Sep 20207:00 amRNSFinal Results
20th Dec 20197:00 amRNSHalf-year Report
6th Nov 20191:18 pmRNSResult of AGM
3rd Oct 201911:15 amRNSNotice of AGM
24th Sep 201910:15 amRNSFinal Results
20th Dec 20188:41 amRNSHalf-year Report
12th Sep 20184:20 pmRNSFinal Results
13th Dec 20177:00 amRNSHalf-year Report
21st Sep 20177:00 amRNSFinal Results
19th Dec 20167:00 amRNSHalf-year Report
22nd Sep 201612:00 pmRNSFinal Results
21st Dec 20158:00 amRNSHalf Yearly Report
30th Oct 201511:38 amRNSResult of AGM
18th Sep 20157:00 amRNSFinal Results
22nd Dec 20147:00 amRNSInterim Results
30th Sep 20147:00 amRNSFinal Results
16th Dec 20137:00 amRNSHalf Yearly Report
30th Sep 20137:00 amRNSFinal Results
9th Sep 201312:03 pmRNSApproval of Share Consolidation
16th Aug 20137:00 amRNSProposed Share Consolidation
18th Jul 201312:44 pmRNSIssue of Equity
21st Dec 20127:00 amRNSHalf Yearly Report
25th Oct 201211:47 amRNSResult of AGM
12th Oct 20127:00 amRNSChange of Registered Office
28th Sep 20127:00 amRNSFinal Results
17th Sep 20127:00 amRNSDirectorate Changes
31st Aug 201211:00 amRNSNew Investments
23rd Aug 201211:00 amRNSNew Investments, Change of Reg Office & Website
21st Aug 20127:00 amRNSName Change Effective
20th Aug 20122:30 pmRNSResult of GM
27th Jul 20121:00 pmRNSIssue of Equity, Directorate Changes, GM Notice
5th Jul 201211:55 amRNSHolding(s) in Company
31st May 20124:43 pmRNSHolding(s) in Company
8th May 20123:39 pmRNSHolding(s) in Company
24th Jan 20122:30 pmRNSHolding(s) in Company
16th Dec 20117:00 amRNSHalf Yearly Report
28th Sep 20117:30 amRNSRestoration - Indian Restaurants Group Plc
28th Sep 20117:00 amRNSFinal Results
26th Aug 20111:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.